MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
Charles River Laboratories International Total Current Liabilities 2011-2026 | CRL
Annual Total Current Liabilities Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.12 B | 994 M | 1.06 B | 1.09 B | 1.03 B | 840 M | 710 M | 558 M | 464 M | 430 M | 312 M | 296 M | 247 M | 342 M | 217 M | 260 M | 250 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.12 B | 217 M | 601 M |
Total Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Castle Biosciences
CSTL
|
68.7 M | $ 20.15 | -1.9 % | $ 584 M |  USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Guardant Health
GH
|
303 M | $ 118.95 | 0.8 % | $ 14.9 B | USA |
 |
Fulgent Genetics
FLGT
|
85 M | $ 17.11 | -1.55 % | $ 517 M | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 116.78 | 0.18 % | $ 9.63 B |  Irlanda |
 |
Agilent Technologies
A
|
1.71 B | $ 114.96 | 0.15 % | $ 34.9 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 138.23 | -3.02 % | $ 6.46 B | USA |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 5.07 | 36.66 % | $ 6.74 M | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 21.63 | 0.28 % | $ 1.15 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 144.41 | -0.29 % | $ 23 B | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.82 | 1.11 % | $ 8.05 M | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 103.0 | 9.03 % | $ 6.95 B | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 432.8 | 0.63 % | $ 12.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 103.09 | 1.16 % | $ 22.7 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 8.47 | 2.67 % | $ 756 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 9.23 | 1.32 % | $ 1.18 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 19.08 | 0.21 % | $ 427 M | USA |
 |
Natera
NTRA
|
310 M | $ 203.19 | -0.25 % | $ 20 B | USA |
 |
Myriad Genetics
MYGN
|
134 M | $ 3.82 | -2.3 % | $ 354 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 6.34 | 2.92 % | $ 265 M | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 60.57 | 2.95 % | $ 3.62 B | USA |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.49 | 2.05 % | $ 5.72 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 259.93 | 1.63 % | $ 21.6 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 448.28 | -0.24 % | $ 169 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 8.9 | 0.45 % | $ 1.93 B | USA |
 |
Waters Corporation
WAT
|
1.24 B | $ 342.37 | 0.4 % | $ 20.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 195.21 | 0.72 % | $ 21.7 B | USA |